WNK1-OSR1 Signaling Regulates Angiogenesis-Mediated Metastasis towards Developing a Combinatorial Anti-Cancer

Chia-Ying Hou1,2, Chung-Yung Ma1, Yu-Ju Lin1

  • 1Institute of Molecular and Genomic Medicine, National Health Research Institutes, Zhunan, Miaoli County 35053, Taiwan.

Insights

Lysine-deficient protein kinase-1 (WNK1) and oxidative stress responsive 1b (OSR1) drive cancer cell migration and angiogenesis. A combination therapy targeting WNK1 and OSR1, with oligo-fucoidan, shows superior efficacy against liver cancer in fish models.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Angiogenesis

Background:

  • Lysine-deficient protein kinase-1 (WNK1) is crucial for angiogenesis in embryonic development and tumors.
  • The downstream targets of WNK1 in these processes, particularly in cancer, are not fully understood.

Purpose of the Study:

  • To elucidate the downstream effectors of WNK1 in tumor-induced angiogenesis and cancer cell migration.
  • To investigate the therapeutic potential of targeting the WNK1 pathway in hepatocellular carcinoma (HCC).

Main Methods:

  • Utilized zebrafish models ([tert x p53] and [HBx,src,p53]) to study angiogenesis and cancer.
  • Employed human umbilical vein endothelial cells (HUVECs) and HepG2 hepatoma cells for in vitro co-culture experiments.
  • Performed gene knockdown and overexpression studies, inhibitor treatments (WNK1, OSR1), and assessed cell migration and senescence markers.

Main Results:

  • Identified oxidative stress responsive 1b (OSR1) as upregulated and protein phosphatase 2A (PP2A) subunit PPP2R1B as downregulated in angiogenesis.
  • Confirmed WNK1 promotes hepatoma cell migration, with OSR1 acting downstream in endothelial cells and PPP2R1A in hepatoma cells.
  • A combination therapy of WNK1 inhibitor (WNK463), OSR1 inhibitor (Rafoxanide), and oligo-fucoidan demonstrated superior anticancer efficacy in HCC fish models compared to Regorafenib, also reducing inflammation and senescence.

Conclusions:

  • The WNK1-OSR1-PPP2R1A axis is a critical regulator of tumor-induced angiogenesis and cancer cell migration.
  • Combined inhibition of WNK1 and OSR1, supplemented with oligo-fucoidan, offers a promising therapeutic strategy for advanced HCC.
  • Oligo-fucoidan may attenuate inflammation and senescence associated with WNK1-OSR1 inhibition, enhancing therapeutic outcomes.

Related Concept Videos

Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.9K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.7K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K